HHS Secretary Xavier Becerra (AP Images)

US gov­ern­ment more than dou­bles the sup­ply of mon­key­pox vac­cine

HHS on Fri­day bought 2.5 mil­lion more dos­es of Bavar­i­an Nordic’s Jyn­neos, an FDA-li­censed vac­cine that’s help­ing to stave off this cur­rent and po­ten­tial­ly fu­ture mon­key­pox out­breaks.

The or­der brings the to­tal vac­cine dos­es to be de­liv­ered in 2022 and 2023 to 4.4 mil­lion, but Bavar­i­an said in a state­ment that de­liv­er­ies un­der this con­tract won’t start un­til Q4 of 2022, and will con­tin­ue through ear­ly 2023. Bavar­i­an al­so said that “the ma­jor­i­ty of the dos­es un­der this con­tract are planned for de­liv­ery in 2023” so it won’t have any ef­fect on the com­pa­ny’s fi­nan­cial guid­ance this year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.